Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/JC.2002-021667PMID 12679461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Listening to silence and understanding nonsense: exonic mutations that affect splicing

  2002cited by this paper
• Genetic Characterization of Growth Hormone Deficiency and Resistance

  2002cited by this paper
• Growth Hormone Insensitivity: Pathophysiology, Diagnosis, Clinical Variation and Future Perspectives

  2001cited by this paper
• A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes

  2001cited by this paper
• Organization and evolution of the human growth hormone receptor gene 5'-flanking region.

  2001cited by this paper
• The exon 3‐retaining and the exon 3‐deleted forms of the growth hormone‐binding protein (GHBP) in human serum are regulated differently

  2001cited by this paper
• Species-specific Alternative Splice Mimicry at the Growth Hormone Receptor Locus Revealed by the Lineage of Retroelements during Primate Evolution

  2000cited by this paper
• Printed in U.S.A. Copyright © 2001 by The Endocrine Society

  2000cited by this paper
• A perfect message: RNA surveillance and nonsense-mediated decay.

  1999cited by this paper
• Activation of Chimeric and Full-length Growth Hormone Receptors by Growth Hormone Receptor Monoclonal Antibodies

  1998cited by this paper
• Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy.

  1997cited by this paper
• The regulation of splice-site selection, and its role in human disease.

  1997cited by this paper
• Molecular basis of inherited growth hormone resistance in childhood.

  1996cited by this paper
• Expression of exon 3-retaining and -deleted human growth hormone receptor messenger ribonucleic acid isoforms during development.

  1996cited by this paper
• Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism.

  1996cited by this paper
• Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein.

  1996cited by this paper
• Expression of exon 3-retaining and exon 3-excluding isoforms of the human growth hormone-receptor is regulated in an interindividual, rather than a tissue-specific, manner.

  1995cited by this paper
• A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH‐binding activity by abolishing receptor homodimerization.

  1994cited by this paper
• Expression of two isoforms of the human growth hormone receptor in normal liver and hepatocarcinoma.

  1994cited by this paper
• Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues.

  1994cited by this paper
• SPECTRUM OF GROWTH HORMONE RECEPTOR MUTATIONS AND ASSOCIATED HAPLOTYPES IN LARON SYNDROME

  1993cited by this paper
• Expression and binding properties of two isoforms of the human growth hormone receptor

  1993cited by this paper
• Functional characterization of the alternatively spliced, placental human growth hormone receptor.

  1993cited by this paper
• Expression of a human growth hormone (hGH) receptor isoform is predicted by tissue-specific alternative splicing of exon 3 of the hGH receptor gene transcript.

  1992cited by this paper
• [Longitudinal physical development of healthy children 0 to 18 years of age. Body length/height, body weight and growth velocity].

  1992cited by this paper
• Rational design of potent antagonists to the human growth hormone receptor.

  1992cited by this paper
• Longitudinale Körperentwicklung gesunder Kinder von 0 bis 18 Jahren

  1992cited by this paper
• Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

  1992cited by this paper
• Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism.

  1991cited by this paper
• Ligand-mediated immunofunctional assay for quantitation of growth hormone-binding protein in human blood.

  1991cited by this paper
• Laron dwarfism and mutations of the growth hormone-receptor gene.

  1989cited by this paper
• The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

  1989cited by this paper
• Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.

  1989cited by this paper
• Identification and characterization of specific binding proteins for growth hormone in normal human sera.

  1986cited by this paper
• A specific growth hormone-binding protein in human plasma: initial characterization.

  1986cited by this paper
• Genetic pituitary dwarfism with high serum concentation of growth hormone--a new inborn error of metabolism?

  1966cited by this paper

• Growth hormone receptor gene polymorphism. Spontaneous catch up growth in small for gestational age patients.

  2021cites this paper
• Detecting novel Indel variants within the GHR gene and their associations with growth traits in Luxi Blackhead sheep

  2020cites this paper
• Anterior Pituitary

  2020cites this paper
• Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I)

  2018cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Clinical and pharmacogenetic aspects of the growth hormone receptor polymorphism.

  2017cites this paper
• The GH receptor exon 3 deletion is a marker of male-specific exceptional longevity associated with increased GH sensitivity and taller stature

  2017cites this paper
• Chapter 23 – Growth Hormone Deficiency in Children∗

  2016cites this paper
• The impact of the d3-growth hormone receptor (d3-GHR) polymorphism on the therapeutic effect of growth hormone replacement in children with idiopathic growth hormone deficiency in Poland.

  2016cites this paper
• Polimorfismo GHRd3 del gen del receptor de la hormona de crecimiento en niños peruanos con talla baja idiopática

  2016cites this paper
• Biological Determinants of Responsiveness to Growth Hormone: Pharmacogenomics and Personalized Medicine

  2016cites this paper
• The Effect of GHR/exon-3 Polymorphism and Serum GH, IGF-1 and IGFBP-3 Levels in Diabetes and Coronary Heart Disease.

  2015cites this paper
• UNCORRECTED PROOF 1 Molecular evolution of growth hormone and insulin-like growth factor 1 2 receptors in long-lived, small-bodied mammals

  2014cites this paper
• Molecular evolution of growth hormone and insulin-like growth factor 1 receptors in long-lived, small-bodied mammals.

  2014cites this paper
• Genetic Disorders of the Pituitary Gland

  2013cites this paper
• siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.

  2013cites this paper
• Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense‐mediated decay

  2012cites this paper
• Polimorfismo do exão 3 do Receptor da Hormona de Crescimento: prevalência, relação genótipo-fenótipo e influência na terapia com hormona de crescimento humana recombinante Experiência Profissionalizante na Vertente de Farmácia Comunitária, Hospitalar e Investigação

  2012cites this paper
• Maturation of the growth axis in marsupials occurs gradually during post-natal life and over an equivalent developmental stage relative to eutherian species.

  2012cites this paper
• Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity.

  2011cites this paper
• Genetics of GHRH, GHRH-receptor, GH and GH-receptor: its impact on pharmacogenetics.

  2011cites this paper
• The exon 3-deleted growth hormone receptor: Molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions

  2011cites this paper
• Genetic defects causing functional and structural isolated growth hormone deficiency

  2011cites this paper
• Exploring the Spectrum of Pituitary Hormone Deficiencies: Genotype, molecular mechanisms and phenotypic variability

  2011cites this paper
• The common exon 3 polymorphism of the growth hormone receptor gene and the effect of growth hormone therapy on growth in Korean patients with Turner syndrome

  2010cites this paper
• Biological determinants of responsiveness to growth hormone: pharmacogenomics and personalized medicine.

  2010cites this paper
• The d3/fl-GH receptor gene polymorphism does not influence quality of life and body composition in GH-deficient adults receiving GH replacement therapy.

  2009cites this paper
• [Association of GHRd3 variant of growth hormone receptor gene with autoimmunity in type 1 diabetes].

  2009cites this paper
• Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.

  2009cites this paper
• Association of GHRd3 variant of growth hormone receptor gene with autoimmunity in type 1 diabetes

  2009cites this paper
• Distribución de las frecuencias alélicas y genotípicas del polimorfismo ghrd3 en pacientes venezolanos con talla baja

  2009cites this paper
• Common exon 3 polymorphism of the GH receptor (GHR) gene and effect of GH therapy on growth in Korean children with idiopathic short stature (ISS)

  2009cites this paper
• Exon 3 of the growth hormone receptor (GH-R) is specific to eutherian mammals.

  2008cites this paper
• Influence of growth hormone (GH) receptor deletion of exon 3 and full-length isoforms on GH response and final height in patients with severe GH deficiency.

  2008cites this paper
• [Novel nonsense mutation (p.Y113X) in the human growth hormone receptor gene in a Brazilian patient with Laron syndrome].

  2008cites this paper
• Common genetic variation in eight genes of the GH/IGF1 axis does not contribute to adult height variation

  2007influential citation
• The growth hormone receptor in growth.

  2007cites this paper
• Relationship between Nocturnal Growth Hormone Concentrations, Serum IGF-I/IGFBP-3 Levels, Insulin Sensitivity and GH Receptor Allelic Variant in Small for Gestational Age Children

  2007cites this paper
• Caracterització molecular del gen GH1 en poblacions control i patològiques, patrons d'expressió en leucòcits de sang perifèrica i estudi funcional de proteïnes mutants detectades en pacients

  2007cites this paper
• Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.

  2007cites this paper
• GHR exon 3 polymorphism: association with type 2 diabetes mellitus and metabolic disorder.

  2007cites this paper
• Growth hormone receptor polymorphisms.

  2007cites this paper
• Growth Hormone Receptor Sequence Changes Do Not Play a Role in Determining Height in Children with Idiopathic Short Stature

  2006cites this paper
• Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders

  2006cites this paper
• Editorial: the pharmacogenomics of human growth.

  2006cites this paper
• The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.

  2006cites this paper
• The Pharmacogenomics of Human Growth

  2006cites this paper
• Physiology and pathophysiology of growth hormone-binding protein: methodological and clinical aspects.

  2006cites this paper
• Fine Structure, Expression, and Polymorphism of the Human Growth Hormone Receptor Gene

  2004cites this paper
• A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone

  2004cites this paper